Medpace Holdings, Inc.
MEDP · Healthcare · Diagnostics & Research · Valued as of 2026-11-03 · Statements 2025-12-31
How Each Value Is Built
The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.
What it is worth
EPV + Growth
4.75B USD
what the normal year's earnings are worth for ever, plus growth that pays
Profit
2.78B USD
15 years of cash the shareholders can take out, and the equity left at year 15
FCFF
1.54B USD
15 years of cash for shareholders and lenders, less what is owed
Average Intrinsic Value
3.03B USD
The plain average of EPV, Profit and FCFF
Against the price
Market Cap
16.71B USD
the price on the date above times the shares
Intrinsic Value ÷ Market Cap
0.18×
the ratio the screener ranks by
Margin of Safety
-452.1%
1 − Market Cap / Average Intrinsic Value
Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.
EPV of the Operations (NOPAT over WACC)
3.75B USD
Net cash today
+382.97M USD
Growth Value
+617.03M USD
Value
4.75B USD
①EPV (earnings power value)
3.75B USD②Net Cash Today
382.97M USD③Growth Value
617.03M USDMarket value
The price on the date above times the shares.
Value vs market
1 minus the market cap as a share of the value.
①Present Value of the 15 Years of FCFE
2.64B USD②Equity at Year 15, Today
142.81M USDMarket value
The price on the date above times the shares.
Value vs market
1 minus the market cap as a share of the value.
①Present Value of the 15 Years of FCFF
1.20B USD②Invested Capital at Year 15, Today
-42.75M USD③Net Cash Today
382.97M USDMarket value
The price on the date above times the shares.
Value vs market
1 minus the market cap as a share of the value.
The Rates and the Capital the Values Read
The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.
The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.
The tax the interest saves.
The interest the company paid: EBIT is the profit before tax plus the interest.
No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.
Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.
The part of the capital the lenders put in, at market value.
Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Total Assets 2.06B USD − Total Liabilities 1.62B USD = Book Value Today 434.29M USD
Total Debt 120.22M USD − Cash and Short-Term Investments 503.19M USD = Net Debt Today -382.97M USD
The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.
Market Data
The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.
Share price
598.68 USD
Enterprise value
16.35B USD
the provider's own figure
EV / EBITDA
26.73×
Price / book
38.47×
the provider's book
Price / earnings
35.10×
Return on equity
162.2%
the provider's figure, not this page's
Profit margin
17.7%
Revenue growth
17.2%
Analyst target, mean
590.51 USD
Analysts
13
opinions in the consensus
Financial Statements
The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.